Microbiota and epigenetic regulation of inflammatory mediators in type 2 diabetes and obesity

Beneficial Microbes

Volumn 5, Issue 1, 2014, Pages 33-43

  Remely, M ^a   Aumueller, E ^a   Jahn, D ^a   Hippe, B ^a   Brath, H ^b   Haslberger, A G ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b Health Center South   (Austria)

Author keywords

Faecalibacterium prausnitzii; Firmicutes Bacteroidetes ratio; LINE 1; Metabolic syndrome; Toll like receptors

Indexed keywords

DNA; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; INSULIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ADULT; ARTICLE; BACTEROIDETES; BODY MASS; CELL WALL; CLINICAL ARTICLE; CLOSTRIDIUM; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPIGENETICS; EXON; FAECALIBACTERIUM PRAUSNITZII; FEMALE; HIGH THROUGHPUT SEQUENCING; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INTESTINE FLORA; LACTIC ACID BACTERIUM; LEAN BODY WEIGHT; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POLYMERASE CHAIN REACTION; PROMOTER REGION; PYROSEQUENCING;

FAECALIBACTERIUM PRAUSNITZII; FIRMICUTES/BACTEROIDETES RATIO; LINE-1; METABOLIC SYNDROME; TOLL-LIKE RECEPTORS;

BACTEROIDETES; BODY MASS INDEX; CLOSTRIDIUM; DIABETES MELLITUS, TYPE 2; DNA METHYLATION; EPIGENOMICS; GASTROINTESTINAL TRACT; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; METABOLIC SYNDROME X; MICROBIOTA; OBESITY; PROMOTER REGIONS, GENETIC; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 84894294507     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2013.006     Document Type: Article

References (59)

1. Abdolrasulnia, M., Menachemi, N., Shewchuk, R.M., Ginter, P.M., Duncan, W.J. and Brooks, R.G., 2008. Market effects on electronic health record adoption by physicians. Health Care Management Review 33: 243-252.
2. Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D.R., Fernandes, G.R., Tap, J., Bruls, T., Batto, J.M., Bertalan, M., Borruel, N., Casellas, F., Fernandez, L., Gautier, L., Hansen, T., Hattori, M., Hayashi, T., Kleerebezem, M., Kurokawa, K., Leclerc, M., Levenez, F., Manichanh, C., Nielsen, H.B., Nielsen, T., Pons, N., Poulain, J., Qin, J., Sicheritz-Ponten, T., Tims, S., Torrents, D., Ugarte, E., Zoetendal, E.G., Wang, J., Guarner, F., Pedersen, O., De Vos, W.M., Brunak, S., Dore, J., Antolin, M., Artiguenave, F., Blottiere, H.M., Almeida, M., Brechot, C., Cara, C., Chervaux, C., Cultrone, A., Delorme, C., Denariaz, G., Dervyn, R., Foerstner, K.U., Friss, C., Van de Guchte, M., Guedon, E., Haimet, F., Huber, W., Van Hylckama-Vlieg, J., Jamet, A., Juste, C., Kaci, G., Knol, J., Lakhdari, O., Layec, S., Le Roux, K., Maguin, E., Merieux, A., Melo Minardi, R., M'Rini, C., Muller, J., Oozeer, R., Parkhill, J., Renault, P., Rescigno, M., Sanchez, N., Sunagawa, S., Torrejon, A., Turner, K., Vandemeulebrouck, G., Varela, E., Winogradsky, Y., Zeller, G., Weissenbach, J., Ehrlich, S.D. and Bork, P., 2011. Enterotypes of the human gut microbiome. Nature 473: 174-180.
3. Baccarelli, A., Tarantini, L., Wright, R.O., Bollati, V., Litonjua, A.A., Zanobetti, A., Sparrow, D., Vokonas, P. and Schwartz, J., 2010. Repetitive element DNA methylation and circulating endothelial and inflammation markers in the VA normative aging study. Epigenetics 5.
4. Backhed, F., Ding, H., Wang, T., Hooper, L.V., Koh, G.Y., Nagy, A., Semenkovich, C.F. and Gordon, J.I., 2004. The gut microbiota as an environmental factor that regulates fat storage. Proceedings of the National Academy of Sciences of the USA 101: 15718-15723.
5. Bayarsaihan, D., 2011. Epigenetic mechanisms in inflammation. Journal of Dental Research 90: 9-17.
6. Blaut, M. and Bischoff, S.C., 2010. Probiotics and obesity. Annals of Nutrition and Metabolism 57 Suppl.: 20-23.
7. Caesar, R., Fak, F. and Backhed, F., 2010. Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism. Journal of Internal Medicine 268: 320-328.
8. Cani, P.D. and Delzenne, N.M., 2009a. Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota. Current Opinion in Pharmacology 9: 737-743.
9. Cani, P.D. and Delzenne, N.M., 2009b. The role of the gut microbiota in energy metabolism and metabolic disease. Current Pharmaceutical Design 15: 1546-1558.
10. Cani, P.D., Amar, J., Iglesias, M.A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A.M., Fava, F., Tuohy, K.M., Chabo, C., Waget, A., Delmee, E., Cousin, B., Sulpice, T., Chamontin, B., Ferrieres, J., Tanti, J.F., Gibson, G.R., Casteilla, L., Delzenne, N.M., Alessi, M.C. and Burcelin, R., 2007. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56: 1761-1772.
11. Cani, P.D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A.M., Delzenne, N.M. and Burcelin, R., 2008a. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57: 1470-1481.
12. Cani, P.D., Delzenne, N.M., Amar, J. and Burcelin, R., 2008b. Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding. Pathologie Biologie 56: 305-309.
13. Caporaso, J.G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F.D., Costello, E.K., Fierer, N., Pena, A.G., Goodrich, J.K., Gordon, J.I., Huttley, G.A., Kelley, S.T., Knights, D., Koenig, J.E., Ley, R.E., Lozupone, C.A., McDonald, D., Muegge, B.D., Pirrung, M., Reeder, J., Sevinsky, J.R., Turnbaugh, P.J., Walters, W.A., Widmann, J., Yatsunenko, T., Zaneveld, J. and Knight, R., 2010. QIIME allows analysis of high-throughput community sequencing data. Nature Methods 7: 335-336.
14. Caricilli, A.M., Nascimento, P.H., Pauli, J.R., Tsukumo, D.M., Velloso, L.A., Carvalheira, J.B. and Saad, M.J., 2008. Inhibition of Toll-like receptor 2 expression improves insulin sensitivity and signaling in muscle and white adipose tissue of mice fed a high-fat diet. Journal of Endocrinology 199: 399-406.
15. Caricilli, A.M., Picardi, P.K., De Abreu, L.L., Ueno, M., Prada, P.O., Ropelle, E.R., Hirabara, S.M., Castoldi, A., Vieira, P., Camara, N.O., Curi, R., Carvalheira, J.B. and Saad, M.J., 2011. Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice. PLoS Biology 9: e1001212.
16. Creely, S.J., McTernan, P.G., Kusminski, C.M., Fisher, F.M., Da Silva, N.F., Khanolkar, M., Evans, M., Harte, A.L. and Kumar, S., 2007. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. American Journal of Physiology - Endocrinology and Metabolism 292: E740-E747.
17. De Kort, S., Keszthelyi, D. and Masclee, A.A., 2010. Leaky gut and diabetes mellitus: what is the link? Obesity Reviews 12: 449-458.
18. Delzenne, N.M. and Cani, P.D., 2011. Interaction between obesity and the gut microbiota: relevance in nutrition. Annual Review of Nutrition 31: 15-31.
19. Di, J.Z., Han, X.D., Gu, W.Y., Wang, Y., Zheng, Q., Zhang, P., Wu, H.M. and Zhu, Z.Z., 2011. Association of hypomethylation of LINE-1 repetitive element in blood leukocyte DNA with an increased risk of hepatocellular carcinoma. Journal of Zhejiang University Science B 12: 805-811.
20. Diamant, M., Blaak, E.E. and De Vos, W.M., 2011. Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes? Obesity Reviews 12: 272-281.
21. DiBaise, J.K., Zhang, H., Crowell, M.D., Krajmalnik-Brown, R., Decker, G.A. and Rittmann, B.E., 2008. Gut microbiota and its possible relationship with obesity. Mayo Clinic Proceedings 83: 460-469.
22. Diesel, B., Ripoche, N., Risch, R.T., Tierling, S., Walter, J. and Kiemer, A.K., 2012. Inflammation-induced up-regulation of TLR2 expression in human endothelial cells is independent of differential methylation in the TLR2 promoter CpG island. Innate Immunity 18: 112-123.
23. Duncan, S.H., Lobley, G.E., Holtrop, G., Ince, J., Johnstone, A.M., Louis, P. and Flint, H.J., 2008. Human colonic microbiota associated with diet, obesity and weight loss. International Journal of Obesity 32: 1720-1724.
24. Furet, J.P., Kong, L.C., Tap, J., Poitou, C., Basdevant, A., Bouillot, J.L., Mariat, D., Corthier, G., Dore, J., Henegar, C., Rizkalla, S. and Clement, K., 2010. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes 59: 3049-3057.
25. Furuta, T., Shuto, T., Shimasaki, S., Ohira, Y., Suico, M.A., Gruenert, D.C. and Kai, H., 2008. DNA demethylation-dependent enhancement of Toll-like receptor-2 gene expression in cystic fibrosis epithelial cells involves SP1-activated transcription. BMC Molecular Biology 9: 39.
26. Gribar, S.C., Anand, R.J., Sodhi, C.P. and Hackam, D.J., 2008. The role of epithelial Toll-like receptor signaling in the pathogenesis of intestinal inflammation. Journal of Leukocyte Biology 83: 493-498.
27. Haehnel, V., Schwarzfischer, L., Fenton, M.J. and Rehli, M., 2002. Transcriptional regulation of the human Toll-like receptor 2 gene in monocytes and macrophages. Journal of Immunology 168: 5629-5637.
28. Himes, R.W. and Smith, C.W., 2010. Tlr2 is critical for diet-induced metabolic syndrome in a murine model. FASEB Journal 24: 731-739.
29. Johnson, C.M. and Tapping, R.I., 2007. Microbial products stimulate human Toll-like receptor 2 expression through histone modification surrounding a proximal NF-kappaB-binding site. Journal of Biological Chemistry 282: 31197-31205.
30. Karlsson, F.H., Tremaroli, V., Nookaew, I., Bergstrom, G., Behre, C.J., Fagerberg, B., Nielsen, J. and Backhed, F., 2013. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498: 99-103.
31. Karlsson, F.H., Ussery, D.W., Nielsen, J. and Nookaew, I., 2010. A closer look at Bacteroides: phylogenetic relationship and genomic implications of a life in the human gut. Microbial Ecology 61: 473-485.
32. Kellermayer, R., Dowd, S.E., Harris, R.A., Balasa, A., Schaible, T.D., Wolcott, R.D., Tatevian, N., Szigeti, R., Li, Z., Versalovic, J. and Smith, C.W., 2011. Colonic mucosal DNA methylation, immune response, and microbiome patterns in Toll-like receptor 2-knockout mice. FASEB Journal 25: 1449-1460.
33. Kim, J.J. and Sears, D.D., 2010. TLR4 and insulin resistance. Gastroenterology Research and Practice 2010: 212563.
34. Larsen, N., Vøgensen, F.K., Van den Berg, F.W., Nielsen, D.S., Andreasen, A.S., Pedersen, B.K., Al-Soud, W.A., Sørensen, S.J., Hansen, L.H. and Jakobsen, M., 2010. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PloS One 5: e9085.
35. Layton, A., McKay, L., Williams, D., Garrett, V., Gentry, R. and Sayler, G., 2006. Development of Bacteroides 16S rRNA gene TaqMan-based real-time PCR assays for estimation of total, human, and bovine fecal pollution in water. Applied and Environmental Microbiology 72: 4214-4224.
36. Leaphart, C.L., Cavallo, J., Gribar, S.C., Cetin, S., Li, J., Branca, M.F., Dubowski, T.D., Sodhi, C.P. and Hackam, D.J., 2007. A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair. Journal of Immunology 179: 4808-4820.
37. Lee, Y.K., Menezes, J.S., Umesaki, Y. and Mazmanian, S.K., 2010. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences of the USA 108 Suppl. 1: 4615-4622.
38. Ley, R.E., Turnbaugh, P.J., Klein, S. and Gordon, J.I., 2006. Microbial ecology: human gut microbes associated with obesity. Nature 444: 1022-1023.
39. Luoto, R., Kalliomaki, M., Laitinen, K. and Isolauri, E., 2010. The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years. International Journal of Obesity 34: 1531-1537.
40. Matsuki, T., Watanabe, K., Fujimoto, J., Kado, Y., Takada, T., Matsumoto, K. and Tanaka, R., 2004a. Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria. Applied and Environmental Microbiology 70: 167-173.
41. Matsuki, T., Watanabe, K., Fujimoto, J., Takada, T. and Tanaka, R., 2004b. Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Applied and Environmental Microbiology 70: 7220-7228.
42. Musso, G., Gambino, R. and Cassader, M., 2010. Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded? Diabetes Care 33: 2277-2284.
43. Nagy-Szakal, D. and Kellermayer, R., 2011. The remarkable capacity for gut microbial and host interactions. Gut Microbes 2: 178-182.
44. Pirker, A., Stockenhuber, A., Remely, M., Harrant, A., Hippe, B., Kamhuber, C., Adelmann, K., Stockenhuber, F. and Haslberger, A.G., 2013. Effects of antibiotic therapy on the gastrointestinal microbiota and the influence of Lactobacillus casei. Food and Agricultural Immunology 24: 315-330.
45. Ramirez-Farias, C., Slezak, K., Fuller, Z., Duncan, A., Holtrop, G. and Louis, P., 2009. Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. British Journal of Nutrition 101: 541-550.
46. Remely, M., Dworzak, S., Hippe, B., Zwielehner, J., Aumüller, E., Brath, H. and Haslberger, A.G., 2013. Abundance and diversity of microbiota in type 2 diabetes and obesity. Journal of Diabetes and Metabolism 4: 253.
47. Schwiertz, A., Taras, D., Schafer, K., Beijer, S., Bos, N.A., Donus, C. and Hardt, P.D., 2010. Microbiota and SCFA in lean and overweight healthy subjects. Obesity 18: 190-195.
48. Semova, I., Carten, J.D., Stombaugh, J., Mackey, L.C., Knight, R., Farber, S.A. and Rawls, J.F., 2012. Microbiota regulate intestinal absorption and metabolism of fatty acids in the zebrafish. Cell Host and Microbe 12: 277-288.
49. Shi, H., Kokoeva, M.V., Inouye, K., Tzameli, I., Yin, H. and Flier, J.S., 2006. TLR4 links innate immunity and fatty acid-induced insulin resistance. Journal of Clinical Investigation 116: 3015-3025.
50. Shuto, T., Furuta, T., Oba, M., Xu, H., Li, J.D., Cheung, J., Gruenert, D.C., Uehara, A., Suico, M.A., Okiyoneda, T. and Kai, H., 2006. Promoter hypomethylation of Toll-like receptor-2 gene is associated with increased proinflammatory response toward bacterial peptidoglycan in cystic fibrosis bronchial epithelial cells. FASEB Journal 20: 782-784.
51. Sommer, F. and Backhed, F., 2012. The gut microbiota - masters of host development and physiology. Nature Reviews Microbiology 11: 227-238.
52. Takahashi, K., Sugi, Y., Hosono, A. and Kaminogawa, S., 2009. Epigenetic regulation of TLR4 gene expression in intestinal epithelial cells for the maintenance of intestinal homeostasis. Journal of Immunology 183: 6522-6529.
53. Takahashi, K., Sugi, Y., Nakano, K., Tsuda, M., Kurihara, K., Hosono, A. and Kaminogawa, S., 2011. Epigenetic control of the host gene by commensal bacteria in large intestinal epithelial cells. Journal of Biological Chemistry 286: 35755-35762.
54. Tsukumo, D.M., Carvalho-Filho, M.A., Carvalheira, J.B., Prada, P.O., Hirabara, S.M., Schenka, A.A., Araujo, E.P., Vassallo, J., Curi, R., Velloso, L.A. and Saad, M.J., 2007. Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 56: 1986-1998.
55. Tsukumo, D.M., Carvalho, B.M., Carvalho-Filho, M.A. and Saad, M.J., 2009. Translational research into gut microbiota: new horizons in obesity treatment. Arquivos Brasileiros de Endocrinologia e Metabologia 53: 139-144.
56. Turcot, V., Tchernof, A., Deshaies, Y., Perusse, L., Belisle, A., Marceau, S., Biron, S., Lescelleur, O., Biertho, L. and Vohl, M.C., 2012. LINE-1 methylation in visceral adipose tissue of severely obese individuals is associated with metabolic syndrome status and related phenotypes. Clinical Epigenetics 4: 10.
57. Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R. and Gordon, J.I., 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027-1031.
58. Vamadevan, A.S., Fukata, M., Arnold, E.T., Thomas, L.S., Hsu, D. and Abreu, M.T., 2010. Regulation of Toll-like receptor 4-associated MD-2 in intestinal epithelial cells: a comprehensive analysis. Innate Immunity 16: 93-103.
59. Walter, J., Hertel, C., Tannock, G.W., Lis, C.M., Munro, K. and Hammes, W.P., 2001. Detection of Lactobacillus, Pediococcus, Leuconostoc, and Weissella species in human feces by using group-specific PCR primers and denaturing gradient gel electrophoresis. Applied and Environmental Microbiology 67: 2578-2585.